Last night, Broadfin Capital, a healthcare focused hedge fund managed by Kevin Kotler, disclosed in a Securities and Exchange Commission filing that it has initiated a 3.5 million...
Keep Reading →
March 6 - Hedge Funds, News
Kevin Kotler’s Broadfin Capital, in its latest filing with the Securities and Exchange Commission, has reported ownership of 9.09 million shares of MELA Sciences Inc (NASDAQ...
Keep Reading →
March 5 - Hedge Funds, News
Broadfin Capital, led by Kevin Kotler, in a filing with the Securities and Exchange Commission, reported initiating a position in Eleven Biotherapeutics, Inc. (NASDAQ:EBIO).
Keep Reading →
February 20 - Hedge Funds, News
Steven Cohen, in a new filing with the SEC disclosed initiating a stake in Retrophin Inc (NASDAQ:RTRX). According to the filing, Mr.
Keep Reading →
January 17 - Hedge Funds, News
Kevin Kotler’s Broadfin Capital has revealed a new stake in Retrophin Inc (NASDAQ:RTRX), which amasses 6.93% of the company’s common stock, it contains 1.61 million shares...
Keep Reading →
January 17 - Hedge Funds, News
Kevin Kotler's Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed.
Keep Reading →
December 30 - Hedge Funds, News
James E. Flynn's healthcare-focused Deerfield Management has revealed, in a new filing with the SEC, initiating a passive stake in Horizon Pharma Inc (NASDAQ:HZNP).
Keep Reading →
December 23 - Hedge Funds, News
Kevin Kotler's Broadfin Capital has increased its position in Derma Sciences Inc (NASDAQ:DSCI).
Keep Reading →
December 20 - Hedge Funds, News
In two newly amended filings with the SEC, Kevin Kotler's Broadfin Capital disclosed moves into Horizon Pharma Inc (NASDAQ:HZNP), and Alliqua Inc (OTCMKTS:ALQAD).
Keep Reading →
November 27 - Hedge Funds, News
Anacor Pharmaceuticals, Geoffrey Parker: In a recent Form 4 filing with the SEC, M.
Keep Reading →
October 7 - Insider Trading, News
Broadfin Capital, Celsus: Broadfin Capital, managed by Kevin Kotler, just disclosed a position in Celsus Therapeutics (OTCQB: CLSXY).
Keep Reading →
October 4 - Hedge Funds, News
Broadfin Capital, Idera Pharmaceuticals: Just now, Kevin Kotler's Broadfin Capital disclosed adding Idera Pharmaceuticals Inc (NASDAQ:IDRA) to its equity portfolio in a filing...
Keep Reading →
October 4 - Hedge Funds, News
Even though passive "hedgies" do not benefit from the same amount of coverage as their activist peers, their moves should also be watched closely.
Keep Reading →
September 18 - Hedge Funds
To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies.
Keep Reading →
September 17 - News
At the moment, there are many indicators market participants can use to watch their holdings. Two of the most under-the-radar are hedge fund and insider trading activity.
Keep Reading →
September 17 - News
To many of your peers, hedge funds are assumed to be delayed, outdated financial tools of a period lost to current times.
Keep Reading →
September 13 - News
If you were to ask many market players, hedge funds are viewed as useless, old investment vehicles of an era lost to time.
Keep Reading →
September 11 - News
At the moment, there are plenty of gauges market participants can use to monitor publicly traded companies.
Keep Reading →
September 9 - News
Now, according to many traders, hedge funds are perceived as useless, old investment vehicles of a period lost to current times.
Keep Reading →
September 6 - News
In the eyes of many investors, hedge funds are viewed as overrated, old investment vehicles of an era lost to time.
Keep Reading →
September 6 - News
Intuitive Surgical makes surgical robots. In early 2009, during the panic, it dropped briefly below $90 per share.
Keep Reading →
September 5 - News
In the financial world, there are plenty of indicators shareholders can use to watch stocks. A couple of the best are hedge fund and insider trading activity.
Keep Reading →
September 3 - News
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Keep Reading →
September 3 - News
In the eyes of many market players, hedge funds are viewed as delayed, outdated financial vehicles of an era lost to time.
Keep Reading →
September 3 - News
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
Keep Reading →
September 3 - News
In the 21st century investor’s toolkit, there are a multitude of methods shareholders can use to track Mr. Market.
Keep Reading →
September 3 - News
In today’s marketplace, there are many gauges market participants can use to track publicly traded companies.
Keep Reading →
September 2 - News
If you were to ask many of your fellow readers, hedge funds are seen as useless, outdated financial vehicles of a period lost to current times.
Keep Reading →
August 30 - News
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
Keep Reading →
August 30 - News
To many investors, hedge funds are viewed as delayed, outdated financial vehicles of a forgotten age.
Keep Reading →
August 29 - News
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
Keep Reading →
August 28 - News
Now, according to many market players, hedge funds are assumed to be bloated, old investment tools of a period lost to current times.
Keep Reading →
August 26 - News
Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm from smart money lately.
Keep Reading →
June 26 - News
Is Solta Medical Inc (NASDAQ:SLTM) worth your attention right now? Investors who are in the know are getting more bullish.
Keep Reading →
June 21 - News
To most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of years past.
Keep Reading →
June 20 - News
In today’s marketplace, there are tons of indicators market participants can use to monitor the equity markets.
Keep Reading →
June 19 - News
In the eyes of most traders, hedge funds are seen as slow, old financial vehicles of years past.
Keep Reading →
June 19 - News
In the financial world, there are a multitude of gauges market participants can use to track their holdings. A couple of the best are hedge fund and insider trading sentiment.
Keep Reading →
June 19 - News
Insulet Corporation (NASDAQ:PODD) was in 14 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
June 14 - News
Insmed Incorporated (NASDAQ:INSM) was in 11 hedge funds' portfolio at the end of March. INSM shareholders have witnessed an increase in enthusiasm from smart money of late.
Keep Reading →
June 14 - News